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Abstract
Background: The definitive diagnosis of glaucoma is currently based on congruent damage to both optic nerve
structure and function. Given widespread quantitative assessment of both structure (imaging) and function
(automated perimetry) in glaucoma, it should be possible to combine these quantitative data to diagnose disease.
We have therefore defined and tested a new approach to glaucoma diagnosis by combining imaging and visual
field data, using the anatomical organization of retinal ganglion cells.
Methods: Data from 1499 eyes of glaucoma suspects and 895 eyes with glaucoma were identified at a single
glaucoma center. Each underwent Heidelberg Retinal Tomograph (HRT) imaging and standard automated
perimetry. A new measure combining these two tests, the structure function index (SFI), was defined in 3 steps: 1)
calculate the probability that each visual field point is abnormal, 2) calculate the probability of abnormality for each
of the six HRT optic disc sectors, and 3) combine those probabilities with the probability that a field point and disc
sector are linked by ganglion cell anatomy. The SFI was compared to the HRT and visual field using receiver
operating characteristic (ROC) analysis.
Results: The SFI produced an area under the ROC curve (0.78) that was similar to that for both visual field mean
deviation (0.78) and pattern standard deviation (0.80) and larger than that for a normalized measure of HRT rim
area (0.66). The cases classified as glaucoma by the various tests were significantly non-overlapping. Based on the
distribution of test values in the population with mild disease, the SFI may be better able to stratify this group
while still clearly identifying those with severe disease.
Conclusions: The SFI reflects the traditional clinical diagnosis of glaucoma by combining optic nerve structure and
function. In doing so, it identifies a different subset of patients than either visual field testing or optic nerve head
imaging alone. Analysis of prospective data will allow us to determine whether the combined index of structure
and function can provide an improved standard for glaucoma diagnosis.
Background
For decades, ophthalmologists have recognized a rela-
tionship between the structure of the optic nerve and its
function in patients with glaucoma [1-4]. Glaucoma
causes death of retinal ganglion cells and their axons,
along with a deformation of the connective tissues of
the optic nerve head. Thus, its structural effects can be
measured both by loss of thickness of the retina in the
ganglion cell and nerve fiber layers and by topographical
changes of the nerve head. The alterations as measured
at the nerve head combine both loss of axons and con-
nective tissue deformation [5].
Glaucomatous functional deficits similarly result from
ganglion cell loss, with defects in visual sensitivity found
in the receptive fields of the damaged neurons. This rela-
tionship between optic nerve head topography and visual
function is so fundamental to our understanding of the
disease that it is used clinically to differentiate damage
due to glaucoma from other diseases of the optic nerve
head. In fact, one or both of these measures have been
used as inclusion criteria and primary outcome measures
in the major clinical trials of glaucoma [6-9] and in a
consensus definition of glaucomatous optic neuropathy
proposed for use in prevalence surveys [10].
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functional, should give information that is highly corre-
lated, since both depend on atrophy of retinal ganglion
cells whose anatomical and physiological features are
known. On the other hand, data from clinical trials have
failed to confirm a strong concordance between changes
in optic nerve and visual field criteria. In the Ocular
Hypertension Treatment Study, for example, treated
subjects met both field and optic nerve criteria for
change only 8% of the time, while 42% reached the
visual field end point alone and 50% reached the optic
disc end point alone [11]. The lack of perfect correlation
between structural and functional diagnostic criteria
may have one or more explanations. For example, it is
known that the variability in testing differs between the
two methods, which could by itself produce poor clinical
correlation. Alternatively, the two approaches might
contain different types of information about the pre-
sence or absence of glaucoma, which, while correlated
by the anatomy of the visual system, nonetheless are
expressed in different ways with different timing from
individual to individual. Thus, using either of these two
measures alone as a “gold standard” for glaucoma diag-
nosis may be a flawed approach.
Hence, the merging of the two sets of data could pro-
vide important corroboration that true abnormality had
developed or was progressing. This has not been pre-
viously done in optimal fashion for a variety of reasons.
First, there has been no attempt to combine quantita-
tively structural and functional deficits using continuous
probabilities of abnormality for each measure. Rather,
specific cut-off criteria at extreme probability levels are
given in current imaging or field analysis. These values
have been chosen to maximize the specificity of each
test, though at the cost of sensitivity. Second, there has
been no consensus regarding a map between the posi-
tion of a field deficit and corresponding structural
changes to the NFL thickness or optic nerve head topo-
graphy. Some proposed models for matching structure
and function used probabilistic approaches that pro-
duced findings inconsistent with known anatomic facts–
linking superior visual field defects to superior optic
disc abnormality, for instance [12-16]. Third, it is possi-
ble that there is temporal dissociation in structural and
functional abnormality development. While NFL photo-
graphs showed abnormality in many cases earlier than
manual visual fields [17], it has recently been proposed
that much of the apparently earlier change in structure
derives from greater variability in field test data [18].
Regardless of the actual nature of temporal discontinuity
in changes to structure and function, use of both
together better reflects the fact that glaucomatous optic
neuropathy displays changes in both structure and
function.
W eb e l i e v eas i n g l em e a s u r ec o m b i n i n gt h e s ee l e -
ments is an improvement for 4 reasons. First, quantita-
tive measures of optic nerve structure and function are
increasingly available and improving in quality. Second,
the discordance between simultaneous progression sug-
gests that both structure and function contain comple-
mentary information. Third, a reliable mapping of visual
field points to the optic nerve head and nerve fiber layer
is available. Finally, modulation of the variability of
structural and functional tests by emphasizing those that
are anatomically related will reduce the overall variabil-
ity of the system. To test the hypothesis that a com-
bined measure of optic nerve structure and function
might be able to detect glaucoma, we designed the
Structure Function Index (SFI) as a model unifying ret-
inal ganglion cell structure and function. The link
between the two was created using our knowledge of
retinal nerve fiber layer anatomy. We then analyzed the
characteristics of the model and compared it to tests of
structure and function alone in terms of distinguishing
eyes with glaucoma from eyes of glaucoma suspects.
Methods
This work was approved by the institutional review
board of the Johns Hopkins University School of Medi-
cine and adhered to the tenets of the Declaration of
Helsinki.
Study Populations
Evaluation of the SFI required three groups of subjects:
1) A reference group of glaucoma suspects to define
“normal” values of tests, 2) a separate but identically
defined group of glaucoma suspects and 3) a group with
glaucoma. The latter two groups were used to compare
the SFI to current diagnostic methods.
We identified subjects for the reference and suspect
groups using billing data to select patients seen by the
Glaucoma Service of the Wilmer Eye Institute between
1999 and 2007 with a diagnosis of glaucoma suspect
(ICD-9 code 365.0x). The criteria for diagnosis of glau-
coma suspect and glaucoma were based on the clinical
judgment of glaucoma specialists using medical history,
past records, and a comprehensive clinical evaluation
including visual field testing and optic nerve examina-
tion. We further refined this list to include those sub-
jects who, on the same day, had both visual field testing
(SITA-Standard 24-2) classified as ‘Reliable’ by the
Humphrey Field Analyzer (HFA, Carl Zeiss Meditec,
Dublin, CA) and optic nerve imaging using the Heidel-
berg Retina Tomograph (HRT, Heidelberg Engineering,
Vista, CA) with image quality that was at least ‘Accepta-
ble’ according to the HRT software. These tests were
c h o s e nb e c a u s et h e yw e r em o s tc o m m o n l yu s e db yt h e
Wilmer Glaucoma Service during this time period.
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of glaucoma (ICD-9 codes 365.[1-9]x) in our database.
Finally, the group identified as glaucoma suspects was
required to achieve a stage of 0 or 1 on the Glaucoma
Staging System [19]. This search returned 1558 eyes.
Data from right and left eyes were analyzed separately
so a given patient was allowed to contribute both eyes
to the reference group. Rather than treating tests from
right and left eyes merely as mirror images, we kept
them separate in order to account for any differences
based on laterality, due to testing order for example.
One thousand of these subjects were randomly selected
as our reference population and the remaining 558 were
placed in the suspect population to be used in evaluating
the SFI.
Similarly, glaucoma cases were identified as those sub-
jects with a diagnosis of open angle glaucoma (ICD-9
365.11), a ‘Reliable’ visual field and at least ‘Acceptable’
quality HRT on the same day.
In cases where both eyes were available for a particu-
lar subject in the suspect or glaucoma groups, the eye
with the worse HFA mean deviation was used in the
analysis described below. This was done since clinicians
w o u l dl i k e l yc l a s s i f yas u b j e c ta sg l a u c o m ai fo n ee y e
were affected, and we did not wish to include fellow
eyes with lesser or no damage in the glaucoma group.
After this selection process, we had 499 eyes from sus-
pects and 895 eyes with glaucoma.
To validate the diagnoses obtained using billing data,
we randomly selected the clinical chart records of 100
subjects identified as glaucoma suspects and 103 sub-
jects identified as having open angle glaucoma. Of the
100 records reviewed for glaucoma suspects, 97 sup-
ported the billing diagnosis based on the clinician’s writ-
ten assessment of the patient. Of the remaining three,
o n eh a da n g l ec l o s u r eg l a u c o m a ,o n eh a dn og l a u c o m a
diagnosis in the chart, and one had neurological disease.
Of 103 records reviewed from those subjects with billing
codes for open angle glaucoma, 99 had glaucoma (one
angle closure), 3 were suspects and 1 had non-glauco-
matous optic nerve disease. Based on this review, we
can therefore estimate that only about 4% of billing
codes do not accurately reflect the clinician’s assess-
ment. Furthermore, the number of misclassified indivi-
duals is similar in each group (suspect and glaucoma) so
there should be no net bias of the classifier
performance.
Defining the Structure Function Index
In brief, the SFI is calculated in three steps: 1) calculate
a probability of abnormality for each point in the visual
field, 2) calculate a probability of abnormality for each
sector of the optic disc, and 3) combine those probabil-
ities with the probability that a visual field point and
optic disc sector are linked by retinal nerve fiber layer
anatomy. As defined, the SFI produces one probability
of structure-function abnormality for each point tested
in the visual field. To allow the SFI to be compared to
current diagnostic criteria, we analyzed these individual
pointwise SFI values in a manner similar to the Glau-
coma Hemifield Test [20].
Definition of Reference Values
To calculate the probability of abnormality for each
visual field point, we require reference data for each of
those points. The probabilities of abnormality reported
by the standard output of the HFA include only a small
number of discrete cutoffs near the far end of the prob-
ability distribution function (p = 5%, 2%, 1%, 0.5%) [21].
They therefore contain no information about probabil-
ities of abnormality less than 95% and are based on reli-
able tests of persons with a normal eye examination. To
generate a continuous probability of abnormality at each
point, we created empiric distributions for the HFA
Total Deviation at each point in the 24-2 visual field for
right and left eyes separately. These distributions were
created using pointwise values from 500 right and 500
left eyes in the reference group defined above. Total
Deviation values were used because they include correc-
tion for age-related decline in visual sensitivity. We
chose not to use Pattern Deviation values as they
include a correction for diffuse loss that we believe will
be unnecessary with the SFI because diffuse field loss
not associated with corresponding nerve damage will be
discounted to a large degree in the SFI calculation.
Second, we extracted HRT data for the 1000 reference
eyes from our clinical database and generated empiric
distributions for the difference between measured rim
area and the rim area predicted by Moorfields regression
analysis (MRA) [22] in each of the six sectors reported
by the HRT. The Moorfields predicted rim area was
used in this way as it includes normalization for both
disc area and age. All HRT data were analyzed using the
HRT-3 software which has an expanded database of
normal subjects [23]. Example distributions of HFA
total deviation and HRT rim area difference values for
our reference population are shown in Figure 1A and B.
Also shown in Figure 1 is the cumulative probability
function (CPF) for both measures. We use the CPF to
define the probability of normality of a particular value.
Less negative values of total deviation or difference from
expected rim area would be expected in normal subjects
and so they have higher values on the CPF (higher prob-
ability of normality). In this way, we obtain a continuous
function describing the degree of abnormality of each
measurement. Corresponding distributions for the 895
subjects in the glaucoma group are shown in Figure 1C
and 1D.
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Disc
The third step in calculating the SFI links rim area to
each field point based on a map developed using nerve
fiber layer defects seen in red-free photographs [24].
This approach bases the relationship of structure and
function on known anatomy rather than on statistical
correlation alone. Briefly, the Garway-Heath group
started with fundus photographs that depicted focal
nerve fiber layer defects. They then used an overlay of
visual field test locations to determine which field points
would have been affected by each defect. Finally, they
measured the angle of insertion of the defect at the
nerve head. After reviewing 69 photographs in this way,
the output of this process was a list of disc insertion
angles for each point in the visual field. In the published
version of this map, the linkage of field position and rim
sector are depicted as absolute, but we extended this
approach by estimating the uncertainty regarding where
each field point maps to the optic disc. To do this, we
obtained the mean and variance for disc insertion angle
for each field point, as measured by Garway-Heath et al.
(personal communication). These data were then used
to estimate the probability that a particular visual field
point is anatomically linked to a particular optic disc
sector, by assuming normal distributions for each field
point and summing the area under this empirically
derived probability distribution in each disc sector. The
process of linking a visual field point to HRT sectors is
shown graphically in Figure 2.
Quantitative Combination of Structure and Function
Once the reference values are available for the tests of
structure, function, and for the anatomical relationship
between the two, the SFI is calculated for each of the 52
points outside the blind spot in the 24-2 pattern visual
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Figure 1 Example distributions of structural and functional data. The distribution of HFA Total Deviation at the point 3 degrees to the right
and 15 degrees above fixation (A), and the distribution of the difference between measured and predicted rim area for the inferior-temporal
sector of right eyes in the reference group (B). The same values from the glaucoma group are plotted in C and D. The line in each figure
represents the cumulative probability function (CPF) for each distribution and helps to demonstrate the probability of normality concept used in
the SFI calculation. Values to the left have low probabilities of normality (low values of the CPF) and values to the right have high probabilities
of normality (high values of CPF).
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above together and summing over all HRT sectors:
SFI P P P    () ( ) ( ) field sector anatomy
All Sectors
(1)
Where P(field) is the probability that the visual field
point is abnormal (one minus the cumulative probability
value defined above), P(sector) is the probability that an
HRT sector is abnormal (using the cumulative probabil-
ity function defined above), and P(anatomy) is the prob-
ability that the visual field point is linked to that sector
of the nerve. Using this formula, the SFI will be close to
0 in cases where the probabilities of abnormality for the
field and disc are small or when the two are unlikely to
be linked by RNFL anatomy. It is also the case that
when there is a modest probability of a defect in func-
tion and a modest probability of a defect in structure,
the fact that the two are in linked by RNFL anatomy
increases the value of the SFI compared to when they
are not linked.
As an explicit example of how the SFI is calculated at
each corresponding visual field point, assume we start
with a visual field total deviation of -7 at the point
3°,15°. The probability that this value is “normal” can be
obtained using the cumulative distribution shown in
Figure 1A. A total deviation of -7 falls at 8% on this
curve indicating that a value this low would only be
expected in 8% of the reference population (i.e., there is
a 92% chance it is abnormal). Next, assume that the
inferior-temporal HRT sector from the same patient has
an actual rim area of 0.25 mm
2 and that the area pre-
dicted by Moorfields regression is 0.20 mm
2. The differ-
ence between these two measures (0.05) falls at the 98%
p o i n to nt h ed i s t r i b u t i o ns h o w ni nF i g u r e1 B( a2 %
chance it is abnormal). Probabilities are similarly calcu-
lated for each HRT sector. To complete our example,
assume that the probability for the inferior-nasal rim
area difference is 84% (16% chance it is abnormal). We
then need to know how likely it is that the visual field
point is anatomically linked to each of the HRT sectors.
For this, we use distributions like the one in Figure 2
which shows that visual field point (3°,15°) is associated
with the inferior-temporal nerve sector in approximately
74% of eyes and with the inferior-nasal sector in 26%.
Since the probability that this visual field point is linked
to the other four HRT sectors is near zero, those sectors
make no contribution to the SFI calculation (i.e., they
add only zero terms to the sum in Equation 1). The
probability values found above are then used to calculate
the value for the SFI at this point: (1-0.08)(1-0.98)(0.74)
+ (1-0.08)(1-0.84)(0.26) = 5.4%. This number then repre-
sents the probability of an abnormal structure-function
relationship at this point in the visual field. The distri-
bution of SFI values in the suspect and glaucoma groups
a tas i n g l ep o i n ta r es h o w ni nF i g u r e3 .S F Iv a l u e sa r e
calculated for all locations in the same way.
The SFI Hemifield Test
As defined above, the SFI produces values for an overall
probability of abnormality corresponding to each point
in the visual field. Since it is known that glaucoma often
affects one hemifield (upper or lower) differentially, due
to the presence of the horizontal raphe, we implemented
an SFI Hemifield Test (SFI-HT) which is an algorithm
similar to the Glaucoma Hemifield Test (GHT) used in
the HFA [20]. Using the same 3 to 6 point clusters,
matched above and below the horizontal meridian, as
defined in the GHT (Figure 4), we calculated a score for
each of the 10 clusters (5 superior and 5 inferior) using:
Region Score
SFI
All points

 
1
10 1 () (2)
As the SFI values within a region become closer to 1
(100% probability of abnormality), the value of the
region score increases. The formula above is derived
directly from that used for calculating region scores in
the GHT. Because this value can reach very high levels
as the SFI value becomes very small, we limited the
score for any one point to a maximum of 100 (SFI value
of 99.9%). The maximum score for a given region
depends on the number of points included (3 to 6) and
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Figure 2 Probability of association between a visual field point
and the optic disc. Probability of insertion around the optic nerve
head for a visual field point 3 degrees to the right and 15 degrees
above fixation in a right eye. The vertical lines indicate boundaries
between the six standard sectors analyzed by the HRT. Calculating
the area under the curve for each sector, the probability of this
point being associated with the inferior-nasal sector is 26% and
with the inferior-temporal sector is 74%.
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Page 5 of 12can therefore range from 300 for region 1 to 600 for
region 4. The difference in the score between paired
superior and inferior regions was then used to identify
defects that might be due to glaucoma.
To define a reference distribution for the difference in
hemifield score for each cluster pair, we again used the
1000 subjects in the reference population defined above.
We calculated the SFI at each point in the visual field,
calculated the region scores, and then calculated the dif-
ferences between corresponding superior and inferior
region pairs. Recognizing that upper to lower differences
disappear when damage is severe in both hemifields, we
also calculated the sum of all SFI-HT region scores.
This value was included in the analysis to account for
eyes with damage too diffuse to produce a significant
superior-inferior difference in scores. Based on the 500
right and 500 left eyes, we were able to generate empiric
distributions for the five differences in hemifield region
scores and for the sum of region scores. When subse-
quently analyzing the glaucoma suspect and glaucoma
subjects, we determined which of these six values was
most statistically abnormal by comparing each to the
corresponding empiric distribution from the reference
population. To allow for receiver operating characteristic
(ROC) analysis to be performed, each subject was sum-
marized with the single largest probability of abnormal-
ity among its five regional score differences (Figure 4)
and sum of all 10 individual region scores (5 upper and
5 lower in Figure 4). The output of the SFI-HT is there-
fore a value between 0 (no chance of being abnormal)
and 1 (100% chance of being abnormal).
Statistical Analysis
The demographics of the glaucoma and glaucoma sus-
pect groups were compared using the t-test for age,
Fisher’s exact test for sex, and the chi-square test for
racial background. The data for race are based on self-
report as recorded in the Johns Hopkins Hospital
patient registration system.
The SFI and the SFI-HT were calculated for each eye
in the glaucoma group and for those eyes in the glau-
coma suspect group that were not used as the reference
population. Receiver operating characteristic analysis
was then performed to characterize the ability of the SFI
to distinguish eyes with glaucoma from eyes of glau-
coma suspects. The probability of the most abnormal
difference in SFI-HT region scores or of the sum of all
SFI values was used as the summary statistic for the SFI
with the clinical diagnosis serving as the “true” classifi-
cation. To compare the SFI-HT to existing diagnostic
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Figure 3 Distribution of Structure Function Index values.
Distribution of values for the structure function index at the point 3
degrees to the right and 15 degrees above fixation in right eyes of
the reference (A) and glaucoma (B) groups.
Figure 4 Regions for the Structure Function Index Hemifield
Test (SFI-HT). Regions defined for the Structure Function Index
Hemifield Test (SFI-HT) in a visual field from a right eye.
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Page 6 of 12criteria that rely on structure or function alone, we per-
formed ROC analysis using the HFA mean deviation
(MD) and the difference between actual and predicted
rim area from the HRT. We also calculated the sensitiv-
ity and specificity of the HFA GHT and the categorical
HRT Moorfields classification (MFC). The results of
these two tests were considered positive for glaucoma
when they were reported as “Outside Normal Limits”.
Areas under the ROC curves were compared using the
method of Hanley and McNeil [25] and confidence
intervals for sensitivity and specificity were calculated
using the method described by Ross [26]. The “optimal”
operating point of the SFI ROC curve was chosen as
that value of the SFI-HT that produced the point closest
to 100% sensitivity and 100% specificity.
Visual field and HRT data were analyzed using Matlab
(version 7.11.0, The Mathworks, Inc., Natick, MA) and sta-
tistical analyses were performed using Matlab, and R ver-
sion 2.11.1 [27] with packages Hmisc [28] and ROCR [29].
Results
The test group of glaucoma suspects was significantly
younger and contained a higher proportion of females
than the glaucoma patients (Table 1). The fact that glau-
coma suspects are younger than those with the disease
is expected from the increasing incidence of glaucoma
with age. The higher proportion of women among the
suspects is not expected, as the prevalence of open
angle glaucoma is similar between sexes. The finding
m a yd e r i v ef r o mt h ek n o w nt e n d e n c yf o rw o m e nt o
make more visits to physicians than men in the United
States and from the fact after age 65 women outnumber
men by 60% to 40% [30]. These differences in the two
groups are not expected to affect subsequent analysis,
since we used measures of structure (difference from
HRT Moorfields predicted rim area) and function (HFA
total deviation) that account for the age of the patient.
The Moorfields regression function used by the HRT to
predict rim area also accounts for disc area, which may
be slightly larger in men [31]. There are no reported dif-
ferences between men and women on visual field test-
i n g ,s ow ed on o te x p e c tt h eh i g h e rp r o p o r t i o no f
women in the suspect group to bias classification. Also,
as expected, the mean deviation (MD) and pattern stan-
dard deviation (PSD) were significantly larger in magni-
tude in the glaucoma group (Table 1). Furthermore,
95% of the suspect group had a MD value greater than
-4 dB. In the glaucoma group, 98% had an MD greater
than -25 dB (Figure 5).
As part of the review of clinical records for 100 of the
glaucoma suspects, we determined that 48% were suspects
based on the appearance of their optic nerve, 23% based
on a history of elevated intraocular pressure, 11% based on
family history, 6% based on the appearance of their ante-
rior chamber angle, 4% based on their visual field, and 8%
for other reasons. A cup-disc ratio was recorded for 189
eyes from these 100 suspects and the mean of these values
was 0.49 with a standard deviation of 0.17. For compari-
son, a documented cup-disc ratio was found for 184 eyes
of the 103 subjects reviewed in the glaucoma group and
the mean was 0.76 with a standard deviation of 0.20.
SFI values were calculated for each member of both
the suspect and glaucoma groups. The 52 SFI values for
each subject were then summarized with a single value
using the SFI-HT. As described above, the SFI-HT is a
single probability value representing the most statisti-
cally abnormal difference between the upper and lower
members of the 5 region pairs or the overall sum of
region scores. To determine which hemifield regions are
Table 1 Characteristics of the glaucoma suspect and
glaucoma patient groups
Glaucoma Suspects
(n = 499)
Glaucoma Patients
(n = 895)
p-value
Age (years) 52(15) 65(13) <0.001
Sex (% female) 65 52 <0.001
Race (%) 0.18
White 69 70
Black 17 17
Asian 3.4 3.2
Hispanic 1.8 0.5
Indian 0.8 0.1
Other 4.0 5.9
Unknown 3.5 3.3
HFA MD (dB) -0.46(1.7) -6.3(8.3) <0.001
HFA PSD (dB) 1.8(1.0) 4.9(4.0) <0.001
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Figure 5 Distribution of visual field mean deviation. Frequency
distribution of visual field mean deviation (MD) in 499 glaucoma
suspects and 895 glaucoma patients.
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Page 7 of 12most likely to be abnormal in each group, the frequency
with which each of these six values (five hemifield dif-
ferences and sum of all regions) was most statistically
abnormal is shown in Figure 6. Regions 1 and 2 and the
sum of all SFI values were all somewhat more likely to
be the most abnormal in subjects with glaucoma than
they were in glaucoma suspects. The fact that these ana-
tomic regions are more likely to be abnormal in persons
with glaucoma may therefore have added significance
for glaucoma diagnosis.
We assessed the ability of the SFI-HT to distinguish
eyes with glaucoma from those that were suspicious for
disease using ROC analysis (Figure 7). The area under
the ROC curve for the SFI-HT was 0.78, indicating fair
performance as a classifier. The area under the ROC
curve for HFA MD was 0.78, for PSD 0.80, and the area
under the curve for the normalized rim area was 0.66.
O n l yt h ea r e au n d e rt h ec u r v ef o rt h en o r m a l i z e dr i m
area was statistically different than that for the SFI (p <
0.001). As categorical variables, the GHT and MFC pro-
duced single values for sensitivity and specificity - 58%
and 91% respectively for the GHT and 64% and 71% for
the MFC. As expected, declaring a subject abnormal if
either the GHT or MFC was abnormal resulted in
higher sensitivity than either test alone (76%) but at the
cost of lower specificity (64%). We also tested the mean
value of the SFI for each subject using ROC analysis
and found that it produced an area under the ROC
curve (0.76) that was not significantly different from the
SFI-HT (0.78), suggesting that the extra computation of
the SFI-HT may not be necessary (data not shown).
To further characterize the performance of the SFI
and other diagnostic tests, we visualized the values of
the tests pairwise for both the suspect and glaucoma
groups. Examples include plots of visual field MD
( F i g u r e8 )a n dH R Td i f f e r e n c ef r o mp r e d i c t e dr i ma r e a
(Figure 9) versus corresponding values of SFI-HT. While
there is a less pronounced relationship between rim area
and the SFI (Figure 9), note that at low values of MD
(Figure 8), the SFI-HT is distributed across a wide range
of values and that almost all of the subjects with high
values of MD also have high values on the SFI-HT.
Because the group with mild disease represents the
greatest diagnostic challenge, we created a Venn
diagram showing the number of subjects with “mild”
disease (MD > -5dB) declared positive by each test
(Figure 10). This subset of the suspect and glaucoma
groups included 1058 (out of 1394) eyes and we consid-
ered the clinical diagnosis as a fourth test of glaucoma.
Of the 572 subjects diagnosed with glaucoma by a clini-
c i a n ,1 3 5( 2 4 % )w e r ep o s i t i v eb ya l lt h r e eo t h e rt e s t s
( G H T ,M F C ,S F I ) .I nas i m i l a rd i a g r a mi n c l u d i n go n l y
those subjects with severe disease (MD < -10dB), the
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Figure 6 Distribution of the most abnormal SFI-HT regions.
Distribution of the statistically most abnormal difference between
corresponding superior and inferior SFI-HT regions for 499 suspect
and 895 glaucoma eyes. The SFI-HT region numbers correspond to
the regions in Figure 3 and Sum refers to the sum of all region
scores (to account for diffuse loss).
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Figure 7 Receiver Operating Characteristic analysis. Receiver
Operating Characteristic (ROC) analysis of the Structure Function
Index Hemifield Test (SFI-HT), Humphrey Field Analyzer Mean
Deviation (MD), pattern standard deviation (PSD) and difference
between predicted and actual Heidelberg Retina Tomograph rim
area. Each test was used to distinguish a group of 499 eyes from
glaucoma suspects from a group of 895 eyes with glaucoma. The
areas under the SFI-HT, MD, PSD, and HRT MRA curves are 0.78,
0.78, 0.80, and 0.66 respectively. The performance of the HFA
Glaucoma Hemifield Test (GHT) and HRT Moorfields Classification
(MFC) are also shown along with the performance of defining as
abnormal any subject with either of these tests outside normal
limits. Error bars represent 95% confidence intervals for sensitivity
and specificity.
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Page 8 of 12fraction positive by all tests was 84% (176 out of 210).
Other interesting aspects of the mild group include the
fact that 172 subjects were positive by clinical diagnosis
only and 118 were positive by only one of the other
three tests (21 SFI, 21 GHT, 76 MFC).
Discussion
These results characterize a potentially new approach to
the diagnosis of glaucoma. Whereas the clinical diagnosis
of glaucoma requires that defects in optic nerve structure
and function should be found together, there is currently
no test available to quantitatively combine measures of
both structure and function. We propose the SFI as such
a test. We have explicitly defined it to overcome some of
the limitations of current testing. First of all, it utilizes
continuous probabilities of abnormality rather than rely-
ing on the highly specific “abnormal” determinations of
each device. The use of continuous probabilities has also
been proposed for analysis of visual field data [32].
A
B
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Figure 8 Relationship between the SFI-HT and visual field
mean deviation. Relationship between the Structure Function
Index Hemifield Test (SFI-HT) and visual field mean deviation (MD)
in the glaucoma suspect group (A) and the glaucoma group (B).
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the Structure Function Index Hemifield Test (SFI-HT) and HFA
difference from predicted rim area in the glaucoma suspect group
(A) and the glaucoma group (B).
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Page 9 of 12Relying on this feature alone might make the SFI prone
to false positive results, however. To overcome this, the
SFI explicitly modulates defects in structure and function
by requiring an anatomic relationship between the two,
thereby augmenting defects that would not reach statisti-
cal significance on either test alone.
The results presented above show some desirable
characteristics of the SFI. We see that the values of the
SFI in the reference population are heavily skewed
toward the expected (lower) values (Figure 3A). At the
same time, the values for the glaucoma population are
more spread out between low and high values (Figure
3B). Since Figure 3 depicts data for a single visual field
location, one would expect such a distribution in the
glaucoma group, as a particular location may not be
affected in some individuals. A similar comment can be
made about Figure 8. The fact that the SFI values are
widely distributed for subjects with “mild” disease
(based on visual field) is expected as this group contains
both normal subjects and those with varying degrees of
early damage. We are now investigating through the use
of longitudinal data whether those with higher levels of
SFI will show more rapid progression, thereby validating
the index. This finding would not be as significant if the
subjects with more severe field loss were also widely dis-
tributed in terms of the SFI. The fact that they are not
suggests that the SFI is not simply a random number
generator.
The ROC data also suggest that the SFI is a useful
synthesis of structure and function. First of all, while the
total area under the curve is not significantly different
from those of MD and PSD, it does show higher sensi-
tivity at the highest specificity values. The Venn diagram
in Figure 10 showing the classification of subjects by
each test also helps with the interpretation of the ROC
curves. While all tests are highly correlated in severe
disease (data not shown), there is significant disagree-
ment for those with the mildest disease shown in the
figure. In other words, each test is classifying (or mis-
classifying) different subjects on the right side of the
ROC plot, the zone containing those with mild disease.
As always, the lack of an accurate test for glaucoma
makes it difficult to compare new to existing methods.
A determination of which diagnostic test (including the
clinician) is correct is not possible using data from a
single point in time. The ultimate evaluation of the SFI
(or any glaucoma test) will be longitudinal studies, now
ongoing, in which development of initial injury will be
compared among all diagnostic tests.
The areas under our ROC curves are lower than some
prior studies using other patient populations and other
diagnostic tests. This is likely due to the fact that we
purposefully studied a challenging classification problem
by attempting to distinguish a group of glaucoma sus-
pects from those classified as glaucoma. Studies that
evaluate the ability to discriminate between eyes with
glaucoma and normals would be expected to find more
striking differences, though this comparison does not
duplicate the problem encountered by clinicians. To
that end, we chose to use glaucoma suspects to define
our normal values since they are, in fact, the group that
clinicians are most often forced to differentiate from
patients with early glaucoma. It is seldom a dilemma in
clinical practice to distinguish a patient with low glau-
coma risk (no family history of glaucoma, normal optic
nerve appearance, normal visual field, normal IOP) from
someone with manifest disc or field change. On the
other hand, it is a frequently encountered problem to
determine which patients with clear risk factors (strong
family history, “suspicious” discs, non-specific field
changes, elevated IOP) have disease and which do not.
By choosing to use suspects as our reference group, we
are therefore making the classification problem more
difficult, but also more applicable to clinical practice.
Previous research on combining measures of structure
and function used regression models that included vari-
ables from various optic nerve analyses and from auto-
mated perimetry [33]. Subsequently, investigators
applied machine learning techniques to combined struc-
tural and functional data [34-37]. While some of these
studies reported an improvement of one kind or another
in the detection of glaucoma, none included the steps of
explicitly combining the structural and functional data
using knowledge of nerve fiber layer topography or the
superior-inferior difference in glaucoma damage. It may
also be possible for a machine learning classifier to “learn”
nerve fiber layer anatomy given enough training data.
SFI
GHT MFC
OAG
21
21 76
172
8
57
39
2
40
56
7
22 101
7
135
Figure 10 Diagnosis of glaucoma by different methods.V e n n
diagram of positive diagnostic tests in the 1058 members of the
suspect and glaucoma groups with visual field mean deviation
greater than -5dB. SFI = Structure Function Index Hemifield Test,
GHT = Glaucoma Hemifield Test, MFC = Moorfields classification,
OAG = clinical diagosis.
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pered by the fact that empiric data contain correlations
between structural and functional defects that are not due
to a cause and effect relationship. For example, when sig-
nificant damage has occurred, correlations between disc
rim loss and decreased field test sensitivity will occur sim-
ply because all points are functionally depressed and not
necessarily because the two are linked by ganglion cell
anatomy. In other words, when the disc and field are both
severely, rather than focally damaged, one will be able to
find correlations between disconnected areas like superior
field points and superior optic nerve parameters. Further-
more, most machine learning classifiers represent “black
boxes” that model knowledge in ways that are not easily
understandable. By explicitly including our knowledge of
the anatomic basis for structure-function correlations in
glaucoma, we avoid the need to “teach” classifiers how
structure and function are related by anatomy in glau-
coma. On the other hand, machine-learning approaches
may provide the benefit of discovering alternative relation-
ships between structure and function in glaucoma, though
this benefit remains to be seen.
Another area of investigation that has some relation-
ship to what we present here is the modeling of struc-
tural and functional changes in glaucoma. Starting with
the assumption that changes in sensitivity at a particular
point in the visual field should correlate closely with
changes in nerve fiber layer thickness or the number of
ganglion cells, both Harwerth et al [38]. and Hood et al
[39]. have proposed linear models of this relationship.
Both have shown significant correlation between struc-
tural and functional measures in both animals and
humans and support the concept that glaucoma pro-
duces changes in both. While these models are useful
for understanding local relationships between loss of
ganglion cells and loss of visual sensitivity, they have
not yet been shown to have application to diagnosis of
disease. Furthermore, the variability in the data used to
create the models and the subsequent uncertainty in the
models themselves suggests that it will be difficult to
apply them to individual patients. By emphasizing anato-
mically meaningful relationships, the SFI may therefore
be a useful tool to bridge the gap between work on local
correlations between structure and function and the sig-
nificant variability that exists within each test alone.
Analysis of our study is clearly limited by the fact that
it was carried out retrospectively. Specifically, the diag-
nostic criteria used by the clinicians as expressed in the
billing code data were not standardized, so there is
potential variability in diagnostic classification. We con-
firmed the validity of our diagnostic coding by reviewing
a subset of charts, revealing a small error rate compared
to the documented clinical impression and no evidence
for bias in misdiagnosis favoring either group. Any
study of glaucoma faces the difficulty that diagnostic cri-
teria are either objective or subjective. When specific
imaging and field criteria are chosen, there is the possi-
bility that expert clinicians would differ on those cri-
teria. When subjective expert judgment is the defining
rule, one must be concerned that the result is not repro-
ducible by some other group of experts. Clinician diag-
nostic biases may therefore be embedded in the
characteristics of the two groups in this study and only
through application of the method to other databases,
collected prospectively, and with a variety of diagnostic
criteria, will the ultimate value of the method be
demonstrated.
A related issue with the glaucoma subjects used to test
the SFI is that a significant portion of them has a visual
field mean deviation with a value greater than 0 (Figure
5). This would imply that the clinicians making the
diagnosis of glaucoma were likely using optic disc or
retinal nerve fiber layer examination to define the pre-
sence of glaucoma. This group of glaucoma patients
with above average field sensitivity could be explained
either by the fact that optic disc change can precede
visual field loss [17] or by mis-diagnosis by the examin-
ing clinician. The latter option again points out the
ambiguity caused by relying on “expert” clinicians to
define the presence or absence of a disease and is some-
thing the SFI might help overcome.
Conclusions
Given the widespread availability of quantitative measures
of optic nerve structure and function, clinicians now must
combine those measures in a subjective manner. We
believe there is a compelling need to develop computa-
tional models that unify visual field and optic nerve ima-
ging data, based on known anatomy, to improve glaucoma
diagnosis. The features of the SFI were intended to expli-
citly model our understanding of changes in optic nerve
structure and function in glaucoma. Furthermore, the
approach we have defined is not restricted to the testing
modalities used here. The SFI could just as easily be calcu-
lated using other tests of visual function (frequency dou-
bling perimetry, short wavelength perimetry, etc.) and
other tests of optic nerve structure (optical coherence
tomography, scanning laser polarimetry). Use of spectral
domain OCT is particularly promising as it may be possi-
ble to image the nerve fiber layer in each retinal region
corresponding to a visual field location. Relating structure
and function in this way would avoid the use of the field-
to-disc maps discussed above.
Based on the characteristics of the SFI in eyes with
glaucoma and those merely suspected of having disease,
we believe further work is warranted and that this
approach, or one like it, might provide a new standard
for diagnosing glaucoma.
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